Down regulation of degenerative cartilage molecules in chondrocytes grown on a hyaluronan-based scaffold

Brunella Grigolo, Luciana De Franceschi, Livia Roseti, Luca Cattini, Andrea Facchini

Research output: Contribution to journalArticle

Abstract

Hyaluronic-acid-based biomaterials used for cartilage repair allow the expression of specific extracellular matrix molecules by human chondrocytes grown onto them. We investigated whether these biomaterials could also create an environment in which the cells downregulate the expression of some catabolic factors. Chondrocytes were isolated from human articular cartilage obtained from the knees of patients with a history of trauma. First, the cells were expanded in monolayers and then they were seeded on a hyaluronic-acid derivative scaffold. Constructs and surnatants were collected and analysed at 1, 3, 7, 14 and 21 days after seeding. Immunohistochemical analysis for CD44 and caspase was carried out on paraffin-embedded sections. The Tunel method was used to identify chondrocyte apoptosis status. Secretion of MMP-1 and MMP-13 in the surnatants of the cells grown onto the biomaterial was measured by enzyme-linked immunosorbent assay. Nitric oxide (NO) production was evaluated by estimating the stable NO metabolite nitrite by the Griess method. A real-time RT-PCR analysis was performed on the constructs to evaluate the expression of type I and II collagens, aggrecan, Sox-9, MMP-1 and MMP-13 mRNAs at the different experimental times evaluated. Decreased levels of metalloproteinases and nitric oxide were observed in the surnatants of chondrocytes grown onto the hyaluronan-based scaffold. This was also confirmed by real-time PCR analysis which showed that the cells expressed the specific differentiated phenotype downregulating the expression of some catabolic molecules. Cells apoptosis decreased during the culture period, which further supported the biochemical data. The ability of the hyaluronan scaffold to reduce the expression and production of molecules involved in cartilage degenerative diseases indicates its use to treat early lesions of osteoarthritic patients.

Original languageEnglish
Pages (from-to)5668-5676
Number of pages9
JournalBiomaterials
Volume26
Issue number28
DOIs
Publication statusPublished - Oct 2005

Fingerprint

Nitric oxide
Cartilage
Hyaluronic Acid
Chondrocytes
Matrix Metalloproteinases
Biomaterials
Scaffolds
Hyaluronic acid
Biocompatible Materials
Down-Regulation
Cell death
Nitric Oxide
Molecules
Apoptosis
Real-Time Polymerase Chain Reaction
Metabolites
Cell culture
Aggrecans
Collagen
Paraffins

Keywords

  • Apoptosis
  • Arthritis
  • Chondrocytes
  • Hyaluronic acid
  • Metalloproteinases

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Biomedical Engineering

Cite this

Down regulation of degenerative cartilage molecules in chondrocytes grown on a hyaluronan-based scaffold. / Grigolo, Brunella; De Franceschi, Luciana; Roseti, Livia; Cattini, Luca; Facchini, Andrea.

In: Biomaterials, Vol. 26, No. 28, 10.2005, p. 5668-5676.

Research output: Contribution to journalArticle

Grigolo, Brunella ; De Franceschi, Luciana ; Roseti, Livia ; Cattini, Luca ; Facchini, Andrea. / Down regulation of degenerative cartilage molecules in chondrocytes grown on a hyaluronan-based scaffold. In: Biomaterials. 2005 ; Vol. 26, No. 28. pp. 5668-5676.
@article{c6bc5ccba5c748d281ea52ddfd54d5c9,
title = "Down regulation of degenerative cartilage molecules in chondrocytes grown on a hyaluronan-based scaffold",
abstract = "Hyaluronic-acid-based biomaterials used for cartilage repair allow the expression of specific extracellular matrix molecules by human chondrocytes grown onto them. We investigated whether these biomaterials could also create an environment in which the cells downregulate the expression of some catabolic factors. Chondrocytes were isolated from human articular cartilage obtained from the knees of patients with a history of trauma. First, the cells were expanded in monolayers and then they were seeded on a hyaluronic-acid derivative scaffold. Constructs and surnatants were collected and analysed at 1, 3, 7, 14 and 21 days after seeding. Immunohistochemical analysis for CD44 and caspase was carried out on paraffin-embedded sections. The Tunel method was used to identify chondrocyte apoptosis status. Secretion of MMP-1 and MMP-13 in the surnatants of the cells grown onto the biomaterial was measured by enzyme-linked immunosorbent assay. Nitric oxide (NO) production was evaluated by estimating the stable NO metabolite nitrite by the Griess method. A real-time RT-PCR analysis was performed on the constructs to evaluate the expression of type I and II collagens, aggrecan, Sox-9, MMP-1 and MMP-13 mRNAs at the different experimental times evaluated. Decreased levels of metalloproteinases and nitric oxide were observed in the surnatants of chondrocytes grown onto the hyaluronan-based scaffold. This was also confirmed by real-time PCR analysis which showed that the cells expressed the specific differentiated phenotype downregulating the expression of some catabolic molecules. Cells apoptosis decreased during the culture period, which further supported the biochemical data. The ability of the hyaluronan scaffold to reduce the expression and production of molecules involved in cartilage degenerative diseases indicates its use to treat early lesions of osteoarthritic patients.",
keywords = "Apoptosis, Arthritis, Chondrocytes, Hyaluronic acid, Metalloproteinases",
author = "Brunella Grigolo and {De Franceschi}, Luciana and Livia Roseti and Luca Cattini and Andrea Facchini",
year = "2005",
month = "10",
doi = "10.1016/j.biomaterials.2005.02.030",
language = "English",
volume = "26",
pages = "5668--5676",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",
number = "28",

}

TY - JOUR

T1 - Down regulation of degenerative cartilage molecules in chondrocytes grown on a hyaluronan-based scaffold

AU - Grigolo, Brunella

AU - De Franceschi, Luciana

AU - Roseti, Livia

AU - Cattini, Luca

AU - Facchini, Andrea

PY - 2005/10

Y1 - 2005/10

N2 - Hyaluronic-acid-based biomaterials used for cartilage repair allow the expression of specific extracellular matrix molecules by human chondrocytes grown onto them. We investigated whether these biomaterials could also create an environment in which the cells downregulate the expression of some catabolic factors. Chondrocytes were isolated from human articular cartilage obtained from the knees of patients with a history of trauma. First, the cells were expanded in monolayers and then they were seeded on a hyaluronic-acid derivative scaffold. Constructs and surnatants were collected and analysed at 1, 3, 7, 14 and 21 days after seeding. Immunohistochemical analysis for CD44 and caspase was carried out on paraffin-embedded sections. The Tunel method was used to identify chondrocyte apoptosis status. Secretion of MMP-1 and MMP-13 in the surnatants of the cells grown onto the biomaterial was measured by enzyme-linked immunosorbent assay. Nitric oxide (NO) production was evaluated by estimating the stable NO metabolite nitrite by the Griess method. A real-time RT-PCR analysis was performed on the constructs to evaluate the expression of type I and II collagens, aggrecan, Sox-9, MMP-1 and MMP-13 mRNAs at the different experimental times evaluated. Decreased levels of metalloproteinases and nitric oxide were observed in the surnatants of chondrocytes grown onto the hyaluronan-based scaffold. This was also confirmed by real-time PCR analysis which showed that the cells expressed the specific differentiated phenotype downregulating the expression of some catabolic molecules. Cells apoptosis decreased during the culture period, which further supported the biochemical data. The ability of the hyaluronan scaffold to reduce the expression and production of molecules involved in cartilage degenerative diseases indicates its use to treat early lesions of osteoarthritic patients.

AB - Hyaluronic-acid-based biomaterials used for cartilage repair allow the expression of specific extracellular matrix molecules by human chondrocytes grown onto them. We investigated whether these biomaterials could also create an environment in which the cells downregulate the expression of some catabolic factors. Chondrocytes were isolated from human articular cartilage obtained from the knees of patients with a history of trauma. First, the cells were expanded in monolayers and then they were seeded on a hyaluronic-acid derivative scaffold. Constructs and surnatants were collected and analysed at 1, 3, 7, 14 and 21 days after seeding. Immunohistochemical analysis for CD44 and caspase was carried out on paraffin-embedded sections. The Tunel method was used to identify chondrocyte apoptosis status. Secretion of MMP-1 and MMP-13 in the surnatants of the cells grown onto the biomaterial was measured by enzyme-linked immunosorbent assay. Nitric oxide (NO) production was evaluated by estimating the stable NO metabolite nitrite by the Griess method. A real-time RT-PCR analysis was performed on the constructs to evaluate the expression of type I and II collagens, aggrecan, Sox-9, MMP-1 and MMP-13 mRNAs at the different experimental times evaluated. Decreased levels of metalloproteinases and nitric oxide were observed in the surnatants of chondrocytes grown onto the hyaluronan-based scaffold. This was also confirmed by real-time PCR analysis which showed that the cells expressed the specific differentiated phenotype downregulating the expression of some catabolic molecules. Cells apoptosis decreased during the culture period, which further supported the biochemical data. The ability of the hyaluronan scaffold to reduce the expression and production of molecules involved in cartilage degenerative diseases indicates its use to treat early lesions of osteoarthritic patients.

KW - Apoptosis

KW - Arthritis

KW - Chondrocytes

KW - Hyaluronic acid

KW - Metalloproteinases

UR - http://www.scopus.com/inward/record.url?scp=18144404654&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18144404654&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2005.02.030

DO - 10.1016/j.biomaterials.2005.02.030

M3 - Article

C2 - 15878372

AN - SCOPUS:18144404654

VL - 26

SP - 5668

EP - 5676

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

IS - 28

ER -